Korean J Anesthesiol reperfusion injury. J Cardiothorac Vasc Anesth 2011; 25: 926-30. 7. Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE. Inhibiting protease- activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling. J Pharmacol Exp Ther 2008; 324: 1045-54. 8. Ebrahimi S, Faghihi M, Keshavarz M, Kadkhodaee M, Mirershadi F, Asadi B. Anti-infarct effect of magnesium is not mediated by adenosine A1 receptors in rat globally ischaemic isolated hearts. Clin Exp Pharmacol Physiol 2004; 31: 868-72. 9. Xi J, McIntosh R, Shen X, Lee S, Chanoit G, Criswell H, et al. Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts. J Mol Cell Cardiol 2009; 47: 684-90. 10. Monahan TS, Sawmiller DR, Fenton RA, Dobson JG Jr. Adenosine A(2a)-receptor activation increases contractility in isolated per- fused hearts. Am J Physiol Heart Circ Physiol 2000; 279: H1472-81. 11. Park SS, Zhao H, Jang Y, Mueller RA, Xu Z. N6-(3-iodobenzyl)- adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. J Pharmacol Exp Ther 2006; 318: 124-31. 12. Navarro-Perán E, Cabezas-Herrera J, Campo LS, Rodríguez-López JN. Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate. Int J Biochem Cell Biol 2007; 39: 2215- 25. 13. Vasara E, Katharou I, Lazou A. Myocardial adenosine does not correlate with the protection mediated by ischaemic or pharmaco- logical preconditioning in rat heart. Clin Exp Pharmacol Physiol 2003; 30: 350-6. 14. Smits GJ, McVey M, Cox BF, Perrone MH, Clark KL. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. J Pharmacol Exp Ther 1998; Lee, et al. 286: 611-8. 15. Safran N, Shneyvays V, Balas N, Jacobson KA, Nawrath H, Shainberg A. Cardioprotective effects of adenosine A1 and A3 receptor acti- vation during hypoxia in isolated rat cardiac myocytes. Mol Cell Biochem 2001; 217: 143-52. 16. Maddock HL, Mocanu MM, Yellon DM. Adenosine A(3) receptor activation protects the myocardium from reperfusion/reoxygena- tion injury. Am J Physiol Heart Circ Physiol 2002; 283: H1307-13. 17. Liang BT. Direct preconditioning of cardiac ventricular myocytes via adenosine A1 receptor and KATP channel. Am J Physiol 1996; 271: H1769-77. 18. Ballard-Croft C, Kristo G, Yoshimura Y, Reid E, Keith BJ, Mentzer RM Jr, et al. Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments. Am J Physiol Heart Circ Physiol 2005; 288: H1359-66. 19. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM. Protection against infarction afforded by precon- ditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-6. 20. Auchampach JA, Rizvi A, Qiu Y, Tang XL, Maldonado C, Teschner S, et al. Selective activation of A3 adenosine receptors with N6-(3- iodobenzyl)-adenosine-5-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res 1997; 80: 800-9. 21. Zhao ZQ, McGee S, Nakanishi K, Toombs CF, Johnston WE, Ashar MS, et al. Receptor-mediated cardioprotective effects of endo- genous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation 1993; 88: 709-19. 22. Philipp S, Yang XM, Cui L, Davis AM, Downey JM, Cohen MV. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res 2006; 70: 308- 14. www.ekja.org 345